DNAJB2 (DNAJ Heat Shock Protein Family Member B2) is a critical co-chaperone protein that plays essential roles in protein quality control within neuronal cells. Located on chromosome 2q32.2, DNAJB2 encodes a member of the DnaJ/Hsp40 family of proteins which function as co-chaperones for Hsp70 family members. The protein contains a characteristic J-domain that enables interaction with Hsp70 family members, facilitating protein folding, refolding, and degradation through the ubiquitin-proteasome system 1. DNAJB2 is particularly important in the nervous system, where it helps prevent aggregation of misfolded proteins that accumulate in various neurodegenerative diseases. Mutations in DNAJB2 cause hereditary spastic paraplegia (SPG43) and have been implicated in amyotrophic lateral sclerosis (ALS) pathogenesis 2.
| DNAJB2 — DNAJ Heat Shock Protein Family Member B2 | |
|---|---|
| Gene Symbol | DNAJB2 |
| Full Name | DNAJ Heat Shock Protein Family (Hsp40) Member B2 |
| Chromosomal Location | 2q32.2 |
| NCBI Gene ID | 7261 |
| OMIM | 604260 |
| Ensembl ID | ENSG00000105971 |
| UniProt | Q9UPE1 |
| Protein Length | 324 amino acids |
| Molecular Weight | ~35 kDa |
| Expression | Brain, spinal cord, peripheral nerves |
| Associated Diseases | [Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia) (SPG43), [ALS](/diseases/amyotrophic-lateral-sclerosis), [Parkinson's Disease](/diseases/parkinsons-disease) |
DNAJB2 is a member of the type II Hsp40 family, characterized by a modular domain architecture:
The N-terminal J-domain is the defining feature of all DnaJ/Hsp40 proteins. This domain contains the highly conserved HPD motif (Histidine-Proline-Aspartate) which is essential for interaction with Hsp70 family proteins 5. The J-domain stimulates the ATPase activity of Hsp70, converting it to its high-affinity state for substrate binding. DNAJB2 possesses a canonical J-domain that interacts with both cytosolic Hsp70 (HSPA1A/Hsc70) and ER-resident Hsp70 (BiP/GRP78).
The G/F domain is unique to type II Hsp40s and contains repeats of glycine and phenylalanine residues. This flexible linker region is thought to provide structural flexibility for substrate binding and inter-domain communication. The G/F domain of DNAJB2 contains multiple Gly-Phe repeats that may contribute to client protein specificity.
The CTD contains a client protein-binding region that recognizes hydrophobic segments of misfolded proteins. This domain also contains a dimerization motif that allows DNAJB2 to form functional homo- and heterodimers with other Hsp40 family members such as DNAJB6 and DNAJB8 4. Dimerization enhances chaperone activity and substrate specificity.
DNAJB2 plays a central role in the cellular protein quality control machinery:
DNAJB2 functions as a co-chaperone for Hsp70 family proteins, facilitating the recognition and refolding of misfolded proteins. The J-domain of DNAJB2 recruits Hsp70 to specific substrates, while the CTD delivers client proteins to the Hsp70 substrate-binding domain. This collaboration prevents protein aggregation and maintains proteostasis 8.
DNAJB2 preferentially targets misfolded proteins for degradation through the ubiquitin-proteasome system (UPS). The protein recognizes substrate proteins with exposed hydrophobic regions and delivers them to the 26S proteasome for degradation 10. This function is particularly important in neuronal cells, which are highly susceptible to proteostatic stress.
DNAJB2 interacts with multiple Hsp70 family proteins:
Recent research has revealed that DNAJB2 regulates mitochondrial dynamics in neurons. Loss of DNAJB2 function leads to mitochondrial fragmentation and impaired axonal transport 12. This function may explain why DNAJB2 mutations cause hereditary spastic paraplegia, a disease characterized by axonal degeneration.
DNAJB2 interacts with multiple proteins implicated in neurodegenerative diseases:
| Disease Protein | Interaction | Functional Consequence |
|---|---|---|
| TDP-43 (TARDBP) | Direct binding | Prevents aggregation; promotes degradation 3 |
| Alpha-synuclein | Direct binding | Prevents fibril formation 7 |
| Huntingtin (polyQ) | Direct binding | Prevents aggregation 9 |
| Tau | Direct binding | Enhances clearance via proteasome 15 |
| SOD1 | Direct binding | Prevents mutant SOD1 aggregation |
DNAJB2 is widely expressed throughout the nervous system:
DNAJB2 localizes to both the cytosol and nucleus. The nuclear localization may be important for handling proteins that require refolding in the nuclear compartment. Within neurons, DNAJB2 concentrates in the soma and dendrites, with lower expression in axons.
DNAJB2 expression is upregulated by:
DNAJB2 mutations cause autosomal recessive hereditary spastic paraplegia type 43 (SPG43), first described in 2014 2. The disease is characterized by:
Clinical Features:
Genetic Basis:
Pathogenesis:
DNAJB2 loss-of-function leads to impaired clearance of misfolded proteins in corticospinal tract neurons, causing axonal degeneration. The inability to properly handle proteostatic stress results in progressive neurodegeneration.
DNAJB2 has been implicated in ALS pathogenesis through multiple mechanisms 3:
Evidence:
Mechanisms:
DNAJB2 plays a protective role in Parkinson's disease models 7:
DNAJB2 represents a promising therapeutic target for neurodegenerative diseases:
Gene Therapy Approaches
Small Molecule Modulators
Protein Aggregation Inhibitors
DNAJB2 expression levels in cerebrospinal fluid may serve as a biomarker for: